New York State Common Retirement Fund
INMB icon

New York State Common Retirement Fund’s INmune Bio INMB Stock Holding History

New York State Common Retirement Fund’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-500
Closed -$565 – 3253
2026
Q1 		$565 Hold
500
– – ﹤0.01% 3129
2025
Q4 		$780 Hold
500
– – ﹤0.01% 3174
2025
Q3 		$1.03K Hold
500
– – ﹤0.01% 3180
2025
Q2 		$1.16K Hold
500
– – ﹤0.01% 3195
2025
Q1 		$3.9K Hold
500
– – ﹤0.01% 3137
2024
Q4 		$2.33K Hold
500
– – ﹤0.01% 3159
2024
Q3 		$2.69K Sell
500
-11,100
-96% -$78.9K ﹤0.01% 3160
2024
Q2 		$102K Buy
+11,600
New +$114K ﹤0.01% 2794

Other funds holding INMB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

New York State Common Retirement Fund's INMB Position: Q2 2026 in Review

New York State Common Retirement Fund sold out of INmune Bio (INMB) in Q2 2026, closing a stake of 500 shares — an estimated $565 sold.

New York State Common Retirement Fund first reported a position in INMB in Q2 2024 and held it in 8 quarters. The position peaked at $102K in Q2 2024. 82 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

  • New York State Common Retirement Fund reported no remaining INmune Bio position as of Q2 2026 after selling out during the quarter.
  • New York State Common Retirement Fund sold 500 INmune Bio shares in Q2 2026, an estimated $565.
  • New York State Common Retirement Fund first reported a position in INmune Bio in Q2 2024 and held it in 8 quarters.
  • New York State Common Retirement Fund's INmune Bio position peaked at $102K in Q2 2024.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.